I think the curve ball is the work Nicky is doing on mechanism of action as applicable to other neurodegenerative conditions, including Parkinson’s and Alzheimers. Expecting to see results on this in 4th qtr, 2024.
A strong result would change addressable market by order of magnitude, and even significant discounting as it is pre-clinical work would see a decent re-rate. And more suitor’s knocking at our door.
I think the curve ball is the work Nicky is doing on mechanism...
-
- There are more pages in this discussion • 60 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add NUZ (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
19.5¢ |
Change
-0.005(2.50%) |
Mkt cap ! $94.89M | |||
| Open | High | Low | Value | Volume |
| 20.0¢ | 20.3¢ | 19.5¢ | $124.5K | 628.4K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 2791 | 19.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 20.0¢ | 62424 | 2 |
View Market Depth
| Last trade - 15.39pm 01/11/2024 (20 minute delay) ? |
| NUZ (ASX) Chart |